Effect of Dolutegravir and Multimonth Dispensing on Viral Suppression Among Children With HIV.

Background: Few studies in sub-Saharan Africa have assessed the impact of multimonth dispensing (MMD) of antiretroviral therapy (ART) and dolutegravir (DTG) beyond clinical trials among children with HIV (CWHIV). We assessed the effect of the 2 interventions on achieving undetectable viral load (VL) among CWHIV in the age group of 0-15 years in Nigeria.

Methods: We used longitudinal routine records and cross-sectional survey data from caregivers of a subsample of children.